Acute care needleless connectors market accounted for a market value of US$ 648.8 Mn in 2017 and projected to grow at a CAGR of 5.1% during the forecast period from 2018 to 2026. The key factors responsible for growth of acute care needleless connectors market are the rising prevalence of needlestick injuries, high awareness related to the advantages of acute care needleless connectors in healthcare personnel, and increasing number of ambulatory centres. According to the World Health Organization (WHO) 1 in 10 healthcare personnel globally sustain a needlestick injury every year.
The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics.
The global botulinum toxin market is growing significantly, and is expected to grow at 7.2% by 2032. Worldwide growing cosmetic & surgical procedures, treatment with botulinum toxin A (BNT-A) for various therapeutic procedures along with growing population aged between 25 to 60 years and growing demand for minimally invasive procedures are the major factors driving the overall growth of the global botulinum toxin market.
Inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from inferior part of the body to the heart. An inferior vena cava filter is implanted in the inferior vena cava to capture embolism, blood clot, preventing them from reaching the lungs. Implantation of these devices is either permanent or temporary depending upon the need of therapy. The prominent factors that fuel the growth of the global inferior vena cava (IVC) filters market include rise in preference for minimally invasive surgeries with improved medical imaging across various medical settings.
Surgical mesh is a medical device constructed by using synthetic materials or animal tissue and used to provide extra support to weak or damaged tissue. Surgical polypropylene mesh widely adopted in the market due to its stability, durability, low infection risk and high mechanical strength.
The actinic keratosis (AK) treatment market is anticipated to grow at a CAGR of about 4.5% during the forecast period 2023-2032. In skin care, occurrence of rough, scaly, crusty, thick patches on the skin surface showing premalignant condition is referred as actinic keratosis.
In vitro fertilization is a form of assisted reproductive technology where the egg is artificially fertilized and later implanted in the womb. This method is widely prevalent in infertile parents, LGBT community and single mothers. The global in vitro fertilization devices and consumables market will undergo rapid growth during the forecast period due to rising infertility rates, delayed pregnancies and surging evolution of assisted reproductive technologies. Innovations in IVF technologies such as introduction of capsule IVF will further add to demand for IVF across the globe.
According to the National Organization of Rare Disorders (NORD), acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. In acquired hemophilia, the body produces antibodies that attack clotting factors, most often factor VIII. Medical practitioners warn that acquired hemophilia can cause life-threatening bleeding complications in severe cases.
Constipation is a very common condition across the world both in adults and children and it impacts the physical and emotional well-being considerably. In adults, the frequency of constipation differs from 2.5% to 79% whereas; in children it is about 0.7% to 29.6%. It has been found that constipation becomes more frequent after the age of 60 years.
The therapeutic Area Market refers to a certain area of diseases or ailments for which there are established medical treatments or prospective remedies in development. It is a method of classifying pharmaceuticals without regard to the type of therapy, mode of action, or manufacturer, but rather by the ailment it treats. Oncology expenditures are predicted to exceed US $300 billion by 2025. With estimated expenditures of roughly US $190 billion, immunology is expected to rank second.
According to the January 2021 publication "The Longitudinal Ageing Study in India (LASI)," around 75 million Indians aged 60 and older suffer from a chronic condition. Around 45 million suffer from cardiovascular disease and hypertension, while 20 million have diabetes. Consequently, the high prevalence of chronic diseases in the country will increase the demand for cost-effective therapies, such as digital therapeutic devices, and drive the market under study. There has been an increase in the therapeutic use of technology for medical ailments. People in developed markets are becoming increasingly aware of the advanced medical treatments available. The Organization for Economic Co-operation and Development said in July 2019 that healthcare spending as a percentage of GDP climbed significantly in 2020, as the economic situation deteriorated and health spending soared in several OECD nations. In 2020, health expenditures per capita for a group of 16 nations are projected to increase by approximately 4.9% on average. So, the choice has turned toward enhanced services in the medical industry, including the rising demand for therapeutic gadget developments. Product approval is another aspect contributing to the expansion of the industry. In December 2020, for instance, the United States Food and Drug Administration granted San Francisco and London-based Mahana Therapeutics a De Novo marketing authorization for a product called Parallel, which according to company literature is an 8-week cognitive behavioral therapy program for people with irritable bowel syndrome. Such approvals will stimulate market expansion.
The increasing prevalence of chronic illnesses contributes to the segment's expansion. According to the International Diabetes Federation (IDF), roughly 536 million adults (20-79 years of age) had diabetes in 2021, and this number will increase to 783 million by 2045. In the majority of countries, the prevalence of type 2 diabetes is increasing, and 79% of adults with diabetes reside in low- and middle-income countries, where 1 in 5 persons over 65 have the disease. In the majority of countries, the prevalence of type 2 diabetes is increasing, and 79% of adults with diabetes reside in low- and middle-income countries, where 1 in 5 persons over 65 have the disease.
Acute Market Reports specializes in market research and consulting for therapeutic area markets. Our clients benefit from Acute Market Reports' futuristic research technique, which enables them to make timely, well-considered business decisions. We work with a wide range of industry participants to give cutting-edge strategic research solutions to our global clients.
